297 related articles for article (PubMed ID: 33084289)
1. The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases.
Evin F; Er E; Ata A; Jalilova A; Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):468-472. PubMed ID: 33084289
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
[TBL] [Abstract][Full Text] [Related]
3. Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study.
Parise M; Tartaglione L; Cutruzzolà A; Maiorino MI; Esposito K; Pitocco D; Gnasso A; Irace C
J Med Internet Res; 2021 Apr; 23(4):e24552. PubMed ID: 33769945
[TBL] [Abstract][Full Text] [Related]
4. Virtual training on the hybrid close loop system in people with type 1 diabetes (T1D) during the COVID-19 pandemic.
Gómez AM; Henao D; Parra D; Kerguelen A; Pinilla MV; Muñoz OM; Rondón M
Diabetes Metab Syndr; 2021; 15(1):243-247. PubMed ID: 33450533
[TBL] [Abstract][Full Text] [Related]
5. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
[TBL] [Abstract][Full Text] [Related]
6. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.
Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M
Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132
[TBL] [Abstract][Full Text] [Related]
7. Rapid Adoption of Telemedicine Along with Emergent Use of Continuous Glucose Monitors in the Ambulatory Care of Young Persons with New-Onset Type 1 Diabetes in the Time of COVID-19: A Case Series.
Kaushal T; Ambler-Osborn L; Turcotte C; Quinn H; Laffel L
Telemed J E Health; 2022 Jan; 28(1):107-114. PubMed ID: 33857385
[No Abstract] [Full Text] [Related]
8. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.
Brener A; Mazor-Aronovitch K; Rachmiel M; Levek N; Barash G; Pinhas-Hamiel O; Lebenthal Y; Landau Z
Acta Diabetol; 2020 Dec; 57(12):1511-1517. PubMed ID: 33026497
[TBL] [Abstract][Full Text] [Related]
9. Caring for a child with type 1 diabetes during COVID-19 lockdown in a developing country: Challenges and parents' perspectives on the use of telemedicine.
Odeh R; Gharaibeh L; Daher A; Kussad S; Alassaf A
Diabetes Res Clin Pract; 2020 Oct; 168():108393. PubMed ID: 32858098
[TBL] [Abstract][Full Text] [Related]
10. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study.
Di Dalmazi G; Maltoni G; Bongiorno C; Tucci L; Di Natale V; Moscatiello S; Laffi G; Pession A; Zucchini S; Pagotto U
BMJ Open Diabetes Res Care; 2020 Oct; 8(2):. PubMed ID: 33115820
[TBL] [Abstract][Full Text] [Related]
12. Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?
Rachmiel M; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Levran N; Chorna E; Dekel M; Barash G; Landau Z; Pinhas-Hamiel O
Acta Diabetol; 2021 Jun; 58(6):697-705. PubMed ID: 33511493
[TBL] [Abstract][Full Text] [Related]
13. The challenge of diabetes home control in COVID-19 times: Proof is in the pudding.
Cotovad-Bellas L; Tejera-Pérez C; Prieto-Tenreiro A; Sánchez-Bao A; Bellido-Guerrero D
Diabetes Res Clin Pract; 2020 Oct; 168():108379. PubMed ID: 32853692
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system.
Christoforidis A; Kavoura E; Nemtsa A; Pappa K; Dimitriadou M
Diabetes Res Clin Pract; 2020 Aug; 166():108307. PubMed ID: 32650036
[TBL] [Abstract][Full Text] [Related]
15. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
[TBL] [Abstract][Full Text] [Related]
16. Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.
Kaushal T; Tinsley LJ; Volkening LK; Turcotte C; Laffel LM
J Clin Endocrinol Metab; 2022 Sep; 107(10):e4197-e4202. PubMed ID: 35948357
[TBL] [Abstract][Full Text] [Related]
17. Management of glucose profile throughout strict COVID-19 lockdown by patients with type 1 diabetes prone to hypoglycaemia using sensor-augmented pump.
Viñals C; Mesa A; Roca D; Vidal M; Pueyo I; Conget I; Giménez M
Acta Diabetol; 2021 Mar; 58(3):383-388. PubMed ID: 33125525
[TBL] [Abstract][Full Text] [Related]
18. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
[TBL] [Abstract][Full Text] [Related]
19. Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities.
Garg SK; Rodbard D; Hirsch IB; Forlenza GP
Diabetes Technol Ther; 2020 Jun; 22(6):431-439. PubMed ID: 32302499
[No Abstract] [Full Text] [Related]
20. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
